BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Biotech catalysts in 2024-12

308 industry Phase 2/3 trial readout(s) and 51 FDA decision event(s). Readouts include completed (ACTUAL) and still-estimated primary completion dates in this month, any status.

← 2024-11 | 2025-01 →

FDA decision events

DateEventStatusCompanyDrugSource
2024-12-04FDA AdComheldAdCom 2024-12-04: Pharmacy Compounding Advisory Committee
2024-12-04FDA approvalapprovedMERUS N.V.BIZENGRIApproved 2024-12-04: BIZENGRI (BLA761352 ORIG1)
2024-12-04FDA approvalapprovedASTRAZENECA UK LTD AZNIMFINZIApproved 2024-12-04: IMFINZI (BLA761069 SUPPL49)
2024-12-05Complete response lettercomplete responseAccord Healthcare Inc.paclitaxel protein-bound particles for injectable suspension (albumin-bound)CRL 2024-12-05: Accord Healthcare Inc. NDA 218762 (paclitaxel protein-bound particles for injectable suspension (albumin-bound))
2024-12-05Complete response lettercomplete responseSandoz Inc.CRL 2024-12-05: Sandoz Inc. BLA 761271
2024-12-05FDA approvalapprovedRENEW PHARMSIC-GREENApproved 2024-12-05: IC-GREEN (NDA011525 SUPPL39)
2024-12-09FDA approvalapprovedNOVO NVORYBELSUSApproved 2024-12-09: OZEMPIC; RYBELSUS (NDA213051 SUPPL20)
2024-12-11Complete response lettercomplete responseFresenius Kabi USA, LLCCRL 2024-12-11: Fresenius Kabi USA, LLC NDA 214610
2024-12-11Complete response lettercomplete responseMeitheal Pharmaceuticals Inc.injectionCRL 2024-12-11: Meitheal Pharmaceuticals Inc. NDA 212271 (injection)
2024-12-11FDA approvalapprovedMERCK SHARP DOHME MRKKEYTRUDAApproved 2024-12-11: KEYTRUDA (BLA125514 SUPPL162)
2024-12-12FDA AdComheldAdCom 2024-12-12: Vaccines and Related Biological Products Advisory Committee
2024-12-12FDA approvalapprovedFIDELITY BIOPHARMA FISONTRALFYApproved 2024-12-12: ONTRALFY (NDA216190 ORIG1)
2024-12-12FDA approvalapprovedMSD SUB MERCKBRIDIONApproved 2024-12-12: BRIDION (NDA022225 SUPPL14)
2024-12-12FDA approvalapprovedORGANON LLC OGNVTAMAApproved 2024-12-12: VTAMA (NDA215272 SUPPL2)
2024-12-13Complete response lettercomplete responseJanssen Biotech, Inc.amivantamabCRL 2024-12-13: Janssen Biotech, Inc. BLA 761433 (amivantamab and hyaluronidase injection)
2024-12-13FDA approvalapprovedNEUROCRINE NBIXCRENESSITYApproved 2024-12-13: CRENESSITY (NDA218808 ORIG1)
2024-12-13FDA approvalapprovedNEUROCRINE NBIXCRENESSITYApproved 2024-12-13: CRENESSITY (NDA218820 ORIG1)
2024-12-13FDA approvalapprovedCHECKPOINT THERAPEUTICS INCUNLOXCYTApproved 2024-12-13: UNLOXCYT (BLA761297 ORIG1)
2024-12-13FDA approvalapprovedVERTEX PHARMS INC VERXORKAMBIApproved 2024-12-13: ORKAMBI (NDA211358 SUPPL6)
2024-12-13FDA approvalapprovedGALDERMA LABS LPNEMLUVIOApproved 2024-12-13: NEMLUVIO (BLA761391 ORIG1)
2024-12-13FDA approvalapprovedVERTEX PHARMS INC VERXORKAMBIApproved 2024-12-13: ORKAMBI (NDA206038 SUPPL18)
2024-12-17Complete response letterapproved sinceCELLTRION, Inc.Steqeyma (ustekinumab-stba) injectionCRL 2024-12-17: CELLTRION, Inc. BLA 761338/Original 2, BLA 761338 (Steqeyma (ustekinumab-stba) injection)
2024-12-17FDA approvalapprovedCELLTRION, INC.STEQEYMAApproved 2024-12-17: STEQEYMA (BLA761338 ORIG1)
2024-12-18FDA approvalapprovedSUMITOMO PHARMA AMGEMTESAApproved 2024-12-18: GEMTESA (NDA213006 SUPPL11)
2024-12-18FDA approvalapprovedJANSSEN PHARMSINVOKAMET XRApproved 2024-12-18: INVOKAMET XR (NDA205879 SUPPL23)
2024-12-18FDA approvalapprovedJANSSEN PHARMSINVOKAMETApproved 2024-12-18: INVOKAMET (NDA204353 SUPPL46)
2024-12-18FDA approvalapprovedJANSSEN PHARMSINVOKANAApproved 2024-12-18: INVOKANA (NDA204042 SUPPL43)
2024-12-18FDA approvalapprovedXCOVERYENSACOVEApproved 2024-12-18: ENSACOVE (NDA218171 ORIG1)
2024-12-18FDA approvalapprovedHIKMACEFAZOLIN SODIUMApproved 2024-12-18: CEFAZOLIN SODIUM (NDA216109 SUPPL3)
2024-12-19Complete response lettercomplete responseZealand Pharma US, Inc.glepaglutide injection proposed for the treatment of short bowel syndrome (SBS)CRL 2024-12-19: Zealand Pharma US, Inc. NDA 218828 (glepaglutide injection proposed for the treatment of short bowel syndrome (SBS))
2024-12-19FDA approvalapprovedGENENTECH INCXOFLUZAApproved 2024-12-19: XOFLUZA (NDA210854 SUPPL21)
2024-12-19FDA approvalapprovedGENENTECH INCXOFLUZAApproved 2024-12-19: XOFLUZA (NDA214410 SUPPL7)
2024-12-19FDA approvalapprovedIONIS PHARMS INC IONSTRYNGOLZAApproved 2024-12-19: TRYNGOLZA (AUTOINJECTOR) (NDA218614 ORIG1)
2024-12-20Complete response lettercomplete responseLexicon Pharmaceuticals, Inc. LXRXCRL 2024-12-20: Lexicon Pharmaceuticals, Inc. NDA 210934
2024-12-20FDA approvalapprovedVERTEX PHARMS INC VERXTRIKAFTAApproved 2024-12-20: TRIKAFTA (COPACKAGED) (NDA212273 SUPPL12)
2024-12-20FDA approvalapprovedELI LILLY AND CO LLYZEPBOUND ZEPBOUND KWIKPENApproved 2024-12-20: ZEPBOUND; ZEPBOUND (AUTOINJECTOR); ZEPBOUND KWIKPEN (NDA217806 SUPPL13)
2024-12-20FDA approvalapprovedVERTEX PHARMS INC VERXALYFTREKApproved 2024-12-20: ALYFTREK (NDA218730 ORIG1)
2024-12-20FDA approvalapprovedRHYTHM RYTMIMCIVREEApproved 2024-12-20: IMCIVREE (NDA213793 SUPPL7)
2024-12-20FDA approvalapprovedBIOGEN US BIIBSKYCLARYSApproved 2024-12-20: SKYCLARYS (NDA216718 SUPPL8)
2024-12-20FDA approvalapprovedNOVO NORDISK INC NVOALHEMOApproved 2024-12-20: ALHEMO (BLA761315 ORIG1)
2024-12-20FDA approvalapprovedVERTEX PHARMS INC VERXTRIKAFTAApproved 2024-12-20: TRIKAFTA (COPACKAGED) (NDA217660 SUPPL3)
2024-12-20FDA approvalapprovedASTRAZENECA AB AZNXIGDUO XRApproved 2024-12-20: XIGDUO XR (NDA205649 SUPPL23)
2024-12-20FDA approvalapprovedARRAY BIOPHARMA INC ADBRAFTOVIApproved 2024-12-20: BRAFTOVI (NDA210496 SUPPL17)
2024-12-23Complete response lettercomplete responseHikma Pharmaceuticals USA Inc.CRL 2024-12-23: Hikma Pharmaceuticals USA Inc. NDA 219357
2024-12-23FDA approvalapprovedNOVA LABS LTD NVMIXROMIApproved 2024-12-23: XROMI (NDA216593 ORIG2)
2024-12-23FDA approvalapprovedBRACCOCARDIOGEN-82Approved 2024-12-23: CARDIOGEN-82 (NDA019414 SUPPL34)
2024-12-23FDA approvalapprovedMYLAN IRELAND LTDARIXTRAApproved 2024-12-23: ARIXTRA (NDA021345 SUPPL52)
2024-12-26FDA approvalapprovedAMGEN INC AMGNWEZLANAApproved 2024-12-26: WEZLANA (BLA761285 SUPPL1)
2024-12-26FDA approvalapprovedBEIGENETEVIMBRAApproved 2024-12-26: TEVIMBRA (BLA761417 ORIG1)
2024-12-27FDA approvalapprovedBRISTOL-MYERS SQUIBB BMYOPDIVO QVANTIGApproved 2024-12-27: OPDIVO QVANTIG (BLA761381 ORIG1)
2024-12-27FDA approvalapprovedBRISTOL-MYERS SQUIBB BMYOPDIVO QVANTIGApproved 2024-12-27: OPDIVO QVANTIG (BLA761429 ORIG1)

Trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2024-12 est.P1/P2Talaris Therapeutics Inc.NCT00497952 Allogeneic Stem Cell Transplantation for the Treatment of Multiple SclerosisMultiple Sclerosiswithdrawn
2024-12 est.P2Health Ever Bio-Tech Co., Ltd.NCT02042807 To Evaluate the Effect of MCS® in Prostate Cancer PreventionProstate Cancerunknown702
2024-12 est.P3Hamad Medical CorporationNCT02455687 Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose ,With/ Without the Nebulized Budesonide For the Management of the Severe Asthma EBronchial Asthmaunknown240
2024-12 est.P1/P2CHABiotech CO., LtdNCT02899091 Evaluation of the Safety and Potential Therapeutic Effects of CB-AC-02 in Patients With Alzheimer's DiseaseAlzheimer's Diseaseunknown24
2024-12 est.P2AZTherapies, Inc.NCT03202147 Safety and Efficacy of ALZT-OP1a as Adjuvant Treatment in Subjects With Post-Ischemic Stroke Cognitive Impairment (PSCI)Ischemic Stroke; Post-stroke Cognitive Impairmentwithdrawn
2024-12 est.P2Philogen S.p.A.NCT03420014 Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA)Leiomyosarcomaunknown114
2024-12 est.P2Gongwin Biopharm Co., Ltd.NCT03447951 A Study of PTS100 in Primary HCC PatientsHepatocellular Carcinomaunknown33
2024-12 est.P3Angiochem IncNCT03613181 ANG1005 in Leptomeningeal Disease From Breast CancerLeptomeningeal Carcinomatosis; Leptomeningeal Metastases; Brain Metastases; HER2-negative Breast Canunknown150
2024-12 est.P2Vasgene Therapeutics, IncNCT03993106 A Study of sEphB4-HSA in Kaposi SarcomaKaposi Sarcomaunknown65
2024-12 est.P2Criterium, Inc.NCT04169347 FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal CancerColorectal Cancer Metastaticunknown27
2024-12 est.P1/P2Celltex Therapeutics CorporationNCT04170426 Autologous Adipose-derived Stem Cells (AdMSCs) for Rheumatoid ArthritisRheumatoid Arthritisnot yet recruiting54
2024-12 est.P3Materia Medica HoldingNCT04250311 Clinical Trial of Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient AdultsInfluenzasuspended314
2024-12 est.P2Shulov Innovate for Science Ltd. 2012NCT04307862 Safety, Tolerability and Efficacy of ZEP-3Na (0.1% or 1%) Compared to Placebo in Subjects With Mild to Moderate Atopic DermatitisAtopic Dermatitisunknown165
2024-12 est.P3AB ScienceNCT04333108 Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic TreatmentIndolent Systemic Mastocytosisunknown140
2024-12 est.P2Anterogen Co., Ltd.NCT04497805 Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot UlcersDiabetic Foot Ulcerunknown64
2024-12 est.P2Samus Therapeutics, Inc.NCT04505358 Evaluate PU-AD in Subjects With Amyotrophic Lateral SclerosisAmyotrophic Lateral Sclerosis (ALS)withdrawn
2024-12 est.P2Rampart Health, L.L.C.NCT04713371 A Phase 2 Trial for Patients With Metastatic Solid CancerMetastatic Cancerunknown32
2024-12 est.P2Shanghai Henlius BiotechNCT04908813 Study of HLX22 in Combanition With Trastuzumab and Chemotherapy Versus Placebo in Combination With Trastuzumab and Chemotherapy for Treatment of Locally AdvanceGastric Cancerunknown150
2024-12 est.P2CuraSen Therapeutics, Inc.NCT04935762 A Study of CST-103 Co-administered With CST-107 in Subjects With Parkinson's Disease Having Freezing of Gait (CLIN-012)Freezing of Gait Symptoms in Parkinson's Diseasewithdrawn
2024-12 est.P1/P2SUNHO(China)BioPharmaceutical CO., Ltd.NCT04980690 Clinical Trial of IBC0966 in Patients With Advanced Malignant TumorsAdvanced Malignant Tumorsunknown228
2024-12 est.P1/P2WestVac Biopharma Co., Ltd.NCT05013983 Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells) in Children and AdolescentsCOVID-19withdrawn
2024-12 est.P3Paracrine, INC.NCT05095389 Adipose Derived Regenerative Cells In the Treatment of Diabetic Foot UlcersDiabetic Foot Ulcerunknown290
2024-12 est.P1/P2Direct Biologics, LLCNCT05127122 Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment for ARDSARDS, Humanwithdrawn
2024-12 est.P2Resilient PharmaceuticalsNCT05173831 Study of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in VeteransPTSDwithdrawn
2024-12 est.P2Eucure (Beijing) Biopharma Co., LtdNCT05212922 A Study to Evaluate YH001 in Combination With Toripalimab in Subjects With Advanced NSCLC and HCCHCC; NSCLC Stage IIIB; NSCLC Stage IVwithdrawn
2024-12 est.P1/P2Rhizen Pharmaceuticals SANCT05246384 Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of RP7214 in Combination With Azacitidine in Patients With Myelodysplastic Syndrome, ChroniMyelodysplastic Syndromes; Chronic Myelomonocytic Leukemia; Acute Myeloid Leukemiawithdrawn
2024-12 est.P1/P2Jubilant Therapeutics Inc. JFILNCT05268666 A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid TumorsLocally Advanced Solid Tumor; Metastatic Solid Tumorunknown126
2024-12 est.P2CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT05325229 A Study of Docetaxel for Injection (Albumin-bound) in Combination With Bevacizumab in Patients With Ovarian CancerPlatinum-resistant Recurrent Ovarian Cancerunknown94
2024-12 est.P1/P2Zhejiang Yangli Pharmaceutical Technology Co., Ltd.NCT05434299 A Study of TFX05-01 in Patients With Advanced Solid TumorsAdvanced Solid Tumorunknown36
2024-12 est.P1/P2CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT05478785 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of Cisplatin Micelle Injection (HA132) in Patients With Advanced MalignanAdvanced Malignant Solid Tumorsunknown126
2024-12 est.P2Q32 Bio Inc. QTTBNCT05509023 Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)Atopic Dermatitisactive not recruiting102
2024-12 est.P1/P2CARE Pharma Shanghai Ltd.NCT05539248 A Study on the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of CAN106 in Subjects With PNHPNH; Hemolysisunknown78
2024-12 est.P2Shanghai Hengrui Pharmaceutical Co., Ltd.NCT05561309 Phase Ⅱ Study of Adductor Canal Block With HR18034 for Postsurgical Pain ManagementTotal Knee Arthroplastyunknown89
2024-12 est.P2Tiziana Life Sciences LTD TLSANCT05651269 Milciclib in Combination With Gemcitabine in Advanced NSCLCNSCLCunknown28
2024-12 est.P3AIM Vaccine Co., Ltd.NCT05682638 A Global Multi-center Clinical Study of SARS-CoV-2 mRNA Vaccine for the Prevention of COVID-19SARS-CoV-2unknown34000
2024-12 est.P1/P2Shanghai Gopherwood Biotech Co., Ltd.NCT05715398 BR790 in Combination With Anlotinib in Adult Subjects With Advanced Non-Small Cell Lung CancerNon-Small Cell Lung Cancerunknown90
2024-12 est.P3FUJIFILM Toyama Chemical Co., Ltd.NCT05777967 Efficacy and Safety of FF-31501 in Meniscus Tear PatientsMeniscus Injuryunknown18
2024-12 est.P1/P2Orient Europharma Co., Ltd.NCT05807529 A Study to Evaluate the Safety and Efficacy of 2ccPA in Patients With Symptomatic Knee OsteoarthritisOsteoarthritis, Kneeunknown136
2024-12 est.P2River 2 Renal Corp.NCT05875948 Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal SyndromeHepatorenal Syndrome; Acute Kidney Injuryrecruiting95
2024-12 est.P3Changchun GeneScience Pharmaceutical Co., Ltd.NCT05919381 Gentuximab Combined With Paclitaxel Compared With Placebo Combined With Paclitaxel for Gastric Adenocarcinoma.Adenocarcinoma of Stomachunknown752
2024-12 est.P1/P2SUNHO(China)BioPharmaceutical CO., Ltd.NCT05991518 IAH0968 in Combination With GC for the Treatment of HER2-Positive Unresectable Advanced/Metastatic Malignant TumorsHER2 Gene Mutationunknown136
2024-12 est.P3Grace Therapeutics Inc. GRCENCT05995405 Safety and Tolerability of GTX-104 Compared with Oral Nimodipine in Patients with ASAHAneurysmal Subarachnoid Hemorrhage (aSAH)active not recruiting100
2024-12 est.P2LG ChemNCT06041841 A Phase 2 Study to Assess Efficacy and Safety of LB54640 in Patients With Genetic ObesityPOMC Deficiency Obesity; PCSK1 Deficiency Obesity; LEPR Deficiency Obesityunknown4
2024-12 est.P2AceLink Therapeutics, Inc.NCT06114329 Study of the Safety and Biologic Activity of AL01211 in Treatment Naive Males With Classic Fabry DiseaseFabry Diseaseunknown16
2024-12 est.P2Constant Therapeutics LLCNCT06135103 Phase 2 Study of TXA127 in Post-ischemic Stroke PatientsIschemic Strokeunknown50
2024-12 est.P3Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. SBFMNCT06169891 A Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute GoutAcute Goutunknown500
2024-12 est.P2Telios Pharma, Inc.NCT06225973 A Study of TL-925 Ophthalmic Emulsion as a Treatment for Dry Eye DiseaseDry Eye Diseaseunknown880
2024-12 est.P2Shanghai Shengdi Pharmaceutical Co., LtdNCT06237257 A Study of Chemoradiotherapy With SHR-1316 For Treatment of Locally Advanced Cervical CancerLocally Advanced Cervical Cancerunknown56
2024-12 est.P3Azura OphthalmicsNCT06329791 A Phase 3 Study to Evaluate AZR-MD-001 in Patients with Abnormal Meibomian Gland Function and Dry Eye Disease (DED)Dry Eye Diseaseunknown500
2024-12 est.P3BiocadNCT06333210 Study of the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of BCD-180 in Patients With Axial Spondyloarthritis (LEVENTA)Axial Spondyloarthritisactive not recruiting421
2024-12 est.P1/P2Starna TherapeuticsNCT06344975 A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine STR-V003 in Healthy AdultsRespiratory Syncytial Virus Infectionsunknown48
2024-12 est.P3Melt PharmaceuticalsNCT06383273 A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)Cataractunknown528
2024-12 est.P2Shaanxi Micot Pharmaceutical Technology Co., Ltd.NCT06533358 A Clinical Study of MT1002 in Subjects With Acute Coronary Syndrome Undergoing PCIAcute Coronary Syndromeunknown20
2024-12 est.P2Gan and Lee Pharmaceuticals, USANCT06558708 A Trial Comparing Efficacy, Tolerability, and Safety of GZR101 Injection Once Daily (OD) and GZR33-70 Injection ODType 2 Diabetesunknown60
2024-12 est.P2Eli Lilly and Company LLYNCT06598631 Efficacy and Safety of Volenrelaxin in Adults With Chronic Kidney DiseaseChronic Kidney Diseasewithdrawn
2024-12 est.P2Code PharmaNCT06676410 Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve ParticHIV; HIV Infectionrecruiting40
2024-12-01 est.P1/P2Telios Pharma, Inc.NCT02825836 Phase I/II, FIH, Dose Escalation Trial of TL-895 and Expansion of TL-895 Monotherapy and Combination Therapy With Navtemadlin in Tx-Naïve and R/R CLL/SLL SubjecRelapsed/Refractory B Cell Malignancies; Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma; Chrunknown130
2024-12-01 est.P3BiocadNCT03912415 Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy With and Without Bevacizumab as First-Line Treatment of Subjects WithCervical Cancerunknown316
2024-12-01 est.P1/P2Suzhou Zelgen Biopharmaceuticals Co.,LtdNCT04445363 A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia AreataAlopecia Areata(AA)unknown160
2024-12-01 est.P3Qilu Pharmaceutical Co., Ltd.NCT04632758 Study Comparing WX-0593 to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) PatientsNon-small Cell Lung Cancerunknown292
2024-12-01 est.P3RemeGen Co., Ltd.NCT04714190 A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-OverexpressionGastric Cancer; HER2 Overexpressing Gastric Carcinomaunknown351
2024-12-01P2Allarity Therapeutics ALLRNCT04796324 Anti-tumor Effect of Ixabepilone in Metastatic Breast Cancer (mBC) Selected by the Ixabepilone DRP.Metastatic Breast Cancerterminated13
2024-12-01P2Sparrow PharmaceuticalsNCT05436639 SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal TumorAutonomous Cortisol Secretion (ACS); ACTH-Independent Cushing Syndrome; ACTH-Independent Adrenal Cuscompleted30
2024-12-01 est.P1/P2LaNova Medicines LimitedNCT05647512 Study of LM-305 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) and Other Plasma Cell DiseasesRelapsed or Refractory Multiple Myeloma; Other Plasma Cell Diseaseswithdrawn
2024-12-01P2Hangzhou Highlightll Pharmaceutical Co., LtdNCT05772520 The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque PsoriasisPlaque Psoriasiscompleted82
2024-12-01 est.P3CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.NCT05783557 A Study of Clevidipine Butyrate Injectable Emulsion in the Treatment of Hypertensive Emergency and Sub-emergencyHypertensive Emergencyunknown398
2024-12-01P1/P2Direct Biologics, LLCNCT05836883 Study of ExoFlo for the Treatment of Perianal FistulasPerianal Fistula; Crohn's Diseaseterminated5
2024-12-01 est.P2Leeuwenhoek Laboratories Co. Ltd.NCT06578143 Effects of Synbiotics on ObesityObesityunknown80
2024-12-02P3CSL BehringNCT04044690 A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM)Dermatomyositisterminated134
2024-12-02P3Pfizer PFENCT04165317 A Study of Sasanlimab in People With Non-muscle Invasive Bladder CancerNon-muscle Invasive Bladder Canceractive not recruiting1068
2024-12-02P2Genmab GMABNCT05117242 Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung CancerNon Small Cell Lung Cancer Metastaticterminated125
2024-12-02P2Novartis Pharmaceuticals NVSNCT05658003 A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive MetastMetastatic Castration-Resistant Prostate Cancer (mCRPC)active not recruiting63
2024-12-02P3Boryung Pharmaceutical Co., LtdNCT05878561 A Study to Evaluate the Efficacy and Safety of BR1015 Combination TherapyEssential Hypertensioncompleted248
2024-12-02P3Hanmi Pharmaceutical Company Limited HAFCNCT06438172 A Study to Evaluate Efficacy and Safety of HCP1803 Compared to RLD2001-1 in Patients with Essential HypertensionHypertensioncompleted249
2024-12-03P2Boehringer IngelheimNCT03697304 Platform Trial Evaluating Safety and Efficacy of Ezabenlimab Anti- PD-1 Based Combination Therapies in PD-(L)1 naïve and PD- (L)1 Pretreated Patient PopulationsNeoplasm Metastasis; Advanced Tumors; Metastatic Solid Tumorscompleted211
2024-12-03P3Axsome Therapeutics, Inc. AXSMNCT04947553 A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease AgitationAgitation in Patients With Dementia of the Alzheimer's Type; Alzheimer Disease; Agitation, Psychomotcompleted456
2024-12-03P2PharmAbcineNCT04986852 Olinvacimab With Pembrolizumab in Patients With mTNBCMetastatic Triple-Negative Breast Cancerterminated19
2024-12-03P1/P2ModernaTX, Inc.NCT05827926 A Study of mRNA-based Influenza and SARS-CoV-2 (COVID-19) Multi-component Vaccines in Healthy AdultsSARS-CoV-2; Influenzacompleted1758
2024-12-03P3Neumora Therapeutics, Inc. NMRANCT06029426 Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive DisorderMajor Depressive Disordercompleted383
2024-12-03P1/P2Ausper Biopharma Co., Ltd.NCT06115993 A Study to Evaluate the Safety and Efficacy of AHB-137 in Healthy Participants and HBeAg-negative Chronic Hepatitis B (CHB) PatientsHepatitis B, Chroniccompleted129
2024-12-04P2Novartis Pharmaceuticals NVSNCT03827798 Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis SuppurativaHidradenitis Suppurativacompleted248
2024-12-04P1/P2AstraZeneca AZNNCT04931654 A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid CancerCarcinoma, Non-Small-Cell Lung; Gastric Cancer; Gastroesophageal Junction Canceractive not recruiting136
2024-12-04P2BayerNCT05171387 Darolutamide + Androgen Deprivation Therapy (ADT) in Chinese Men With High Risk, Nonmetastatic Prostate CancerProstate Cancercompleted78
2024-12-04P2Integrative Research Laboratories ABNCT05258071 A Clinical Study Evaluating Efficacy of Pirepemat on Falls Frequency in Patients With Parkinson's Disease (PD)Parkinson Diseasecompleted104
2024-12-04P2LB Pharmaceuticals Inc. LBRXNCT06179108 Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute SchizophreniaSchizophreniacompleted359
2024-12-04P2Dompé Farmaceutici S.p.ANCT06244316 A Safety and Efficacy Study of 2 Dosing Regimens of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution Compared With Vehicle in Patients With Dry EDry Eye Diseasecompleted317
2024-12-04P2AstraZeneca AZNNCT06336356 A Study to Evaluate Cortisol Reserve in Response to Adrenocorticotropic Hormone (ACTH) Stimulation Test Following Baxdrostat Treatment Compared to Placebo in PaUncontrolled Hypertensioncompleted48
2024-12-04P2Medibiofarma S.L.NCT06469853 Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of MBF-015 in Huntington's Disease PatientsHuntington Diseasecompleted10
2024-12-04 est.P3Genrix (Shanghai) Biopharmaceutical Co., Ltd.NCT06635798 A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR2001 InjectionTetanusunknown582
2024-12-05 est.P3Vanda Pharmaceuticals VNDANCT01218789 Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light PerceptionNon 24 Hour Sleep Wake Disorderunknown140
2024-12-05P3Anterogen Co., Ltd.NCT04569409 Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers.Diabetic Foot Ulcercompleted104
2024-12-05P2AbbVie ABBVNCT04686786 An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset SeizuresSeizuresterminated105
2024-12-05P3LEO PharmaNCT05355818 Efficacy and Safety of Delgocitinib Cream in Adolescents 12-17 Years of Age With Moderate to Severe Chronic Hand EczemaChronic Hand Eczemacompleted98
2024-12-05P2Oxular LimitedNCT05697809 Suprachoroidal Sustained-Release OXU-001 Compared to Intravitreal Ozurdex® in the Treatment of Diabetic Macular EdemaDiabetic Macular Edemacompleted3
2024-12-05P2Guangzhou Lupeng Pharmaceutical Company LTD.NCT05716087 A Study of Rocbrutinib in Participants With Relapse or Refractory Mantle Cell LymphomaMantle Cell Lymphoma (MCL)active not recruiting62
2024-12-05P3Astrogen, Inc.NCT06333964 A Study to Evaluate the Efficacy and Safety of AST-001 in ASD ChildrenAutism Spectrum Disordercompleted169
2024-12-05P2/P3NGM Biopharmaceuticals, IncNCT06654726 A Multi-center Evaluation of Aldafermin in a Randomized, Double-blind, Placebo-controlled Study in Subjects With Primary Sclerosing Cholangitis.Primary Sclerosing Cholangitiswithdrawn
2024-12-06P2Nuvation Bio Inc. NUVBNCT04617054 Phase II Study of AB-106 to Treat Patients With Solid Tumors With NTRK Gene FusionSolid Tumorterminated14
2024-12-06P3AkesoNCT05008783 A Study of AK104 in the First-line Treatment of Locally Advanced Unresectable or Metastatic G/GEJ AdenocarcinomaGastric Adenocarcinoma; Gastroesophageal Junction Adenocarcinomacompleted610
2024-12-06P3Nuance Pharma (shanghai) Co., LtdNCT05743075 A Study to Evaluate the Efficacy and Safety of Ensifentrine for 24 Weeks in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Diseasecompleted526
2024-12-06P3Otsuka Australia Pharmaceutical Pty LtdNCT05883956 A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or ChMyelodysplastic Syndromes; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Patient Prefactive not recruiting13
2024-12-06P3Takeda TAKNCT06108544 A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Plaque Psoriasiscompleted1108
2024-12-06P1/P2Hangzhou Grand Biologic Pharmaceutical, Inc.NCT07752810 Study of Safety, PK, and Efficacy of Multiple Ascending Doses of HZBio1 in Patients With GoutGoutcompleted90
2024-12-08P2Swedish Orphan BiovitrumNCT05148299 A Study of Pegcetacoplan for Patients With Transplant-associated Thrombotic Microangiopathy After Hematopoietic Stem Cell TransplantationTransplant-Associated Thrombotic Microangiopathycompleted12
2024-12-09P1/P2Persica Pharmaceuticals LtdNCT04238676 Persica 002 Phase 1b PP353 vs Placebo in the Treatment of Low Back PainChronic Low-back Paincompleted43
2024-12-09P2Alexion Pharmaceuticals, Inc.NCT05097989 Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)Lupus Nephritis; Immunoglobulin A Nephropathy; IgAN; LNterminated100
2024-12-09P1/P2Intralytix, Inc.NCT05182749 Safety and Efficacy of the Bacteriophage Preparation, ShigActive™, in a Human Experimental Model of ShigellosisShigellosisactive not recruiting52
2024-12-09P3IBSA Institut Biochimique SANCT05490680 A New Sildenafil Oral Film in Patients With Erectile DysfunctionErectile Dysfunctioncompleted488
2024-12-09P2Cardiff Oncology CRDFNCT05593328 Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in ParColorectal Cancer; Metastatic Colorectal Cancercompleted23
2024-12-09P3Hoffmann-La RocheNCT05642312 A Study to Investigate Vamikibart in Participants With Uveitic Macular EdemaUveitic Macular Edemacompleted245
2024-12-09P3AbbVie ABBVNCT05741034 A Study to Assess Adverse Events and Effectiveness of Injected JUVÉDERM® VOLITE™ Gel Filler for Change in Neck Lines in Adult Chinese ParticipantsNeck Linescompleted159
2024-12-09P2Atea Pharmaceuticals, Inc. AVIRNCT05904470 A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCVChronic Hepatitis C Virus; Hepatitis C, Chronic; Hepatitis C; Hepatic Cirrhosis; HCVcompleted275
2024-12-09P3Colgate Palmolive CLNCT06607263 Comparative Study of CPC+Zn Mouthwash, Dental Floss, and Essential Oils Mouthwash on Plaque and Gingivitis ReductionGingival Bleeding; Plaque Induced Gingival Disease; Gingivitis and Periodontal Diseasescompleted120
2024-12-10P2Eisai Inc.NCT01767311 A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's DiseaseAlzheimer's Diseasecompleted856
2024-12-10P1/P2Bolt Biotherapeutics, Inc. BOLTNCT04278144 A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid TumorsHER2-positive Solid Tumors; HER2-positive Breast Cancer; HER2-positive Colorectal Cancer; HER2-positterminated175
2024-12-10P2Medolution Ltd.NCT04824079 Keynatinib in Treated Patients With NSCLC and Brain MetastasesNon-Small Cell Lung Cancer With EGFR Mutation; Brain Metastasescompleted16
2024-12-10P2Merck Sharp & Dohme LLC MRKNCT05005442 A Study of Pembrolizumab/Vibostolimab (MK-7684A) in Relapsed/Refractory Hematological Malignancies (MK-7684A-004, KEYVIBE-004)Hematological Malignanciescompleted192
2024-12-10 est.P1/P2Kecellitics Biotech Company LtdNCT05651100 Safety and Efficacy of Sequential CD19 and CD22 Targeted CAR-T Therapy for Relapsed/Refractory B Cell LymphomaLymphoma, B-Cellunknown50
2024-12-10P3Tonghua Dongbao Pharmaceutical Co.,LtdNCT05834868 Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 2 DiabetesType 2 Diabetescompleted1040
2024-12-10P2InnoCare Pharma Inc.NCT05978739 Evaluating Different Doses of Orelabrutinib in MCLMantle Cell Lymphomacompleted40
2024-12-10P3Mineralys Therapeutics Inc. MLYSNCT06153693 Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant HypertensionHypertensioncompleted1083
2024-12-10 est.P2Telios Pharma, Inc.NCT06686472 Evaluation of TL-925 for the Treatment of Allergic ConjunctivitisAllergic Conjunctivitisrecruiting66
2024-12-11P2Rapamycin Holdings Inc.NCT04230499 Trial of eRapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active SurveillanceFamilial Adenomatous Polyposiscompleted30
2024-12-11P2LEO PharmaNCT05923099 A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic DermatitisAtopic Dermatitiscompleted262
2024-12-11P2AkesoNCT06061471 To Evaluate the Efficacy and Safety of AK111 Injection in the Treatment of Moderate to Severe Plaque PsoriasisPsoriasis; Skin Diseasescompleted454
2024-12-11P2AstraZeneca AZNNCT06269484 A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOCKLiver Cirrhosiscompleted73
2024-12-11P2ITB-Med LLCNCT06365437 A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal TransplantationKidney Transplantationterminated33
2024-12-12P1/P2Autolus Limited AUTLNCT03590574 Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell LymphomaT Cell Non-Hodgkin Lymphoma; Peripheral T-Cell Lymphoma, Not Otherwise Specified; Angioimmunoblasticterminated20
2024-12-12P1/P2PureTech PTCHFNCT04666688 LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid TumorsMetastatic Cancer; Solid Tumor; Head and Neck Cancercompleted44
2024-12-12P2AbbVie ABBVNCT05041257 Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube CancersOvarian Cancer; Peritoneal Cancer; Fallopian Tube Cancercompleted79
2024-12-12P2BioGaia Pharma ABNCT05133076 Safety and Preliminary Efficacy of BGP345A in Constipation Due to Opioid-based MedicationsOpioid-Induced Constipationcompleted14
2024-12-12P1/P2Aminex Therapeutics, Inc.NCT05500508 Oral AMXT 1501 Dicaprate in Combination With IV DFMOCancer; Solid Tumor; Solid Carcinoma; Advanced Cancer; DIPG Brain Tumor; Ovary Cancer; Breast Cancerterminated15
2024-12-12P2Merck Sharp & Dohme LLC MRKNCT06045507 Safety and Pharmacokinetic Study of Oral MK-8527 QM in Participants at Low-Risk for HIV-1 Infection (MK-8527-007)HIV; HIV Pre-exposure Prophylaxiscompleted352
2024-12-12P3Shenzhen HighTide Biopharmaceutical Ltd.NCT06350890 Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 DiabetesT2DM (Type 2 Diabetes Mellitus)completed408
2024-12-12P3Shenzhen HighTide Biopharmaceutical Ltd.NCT06353347 Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With MetforminType 2 Diabetes Mellituscompleted551
2024-12-12P2Revance Therapeutics, Inc.NCT06411002 Phase 2a Study of DaxibotulinumtoxinA-lanm for Injection in Dynamic Forehead Lines and Glabellar LinesGlabellar Frown Linescompleted27
2024-12-12P2Reinovax Biologics Co., LTDNCT06678620 Phase II Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate VaccinePneumococcal Infectious Diseasecompleted992
2024-12-12P2Shenyang Sunshine Pharmaceutical Co., LTD.NCT07014631 Phase II Dose-Finding of Oral SSS17 for Anemia in Non-Dialysis CKDAnemia in Pre-Dialysis Patientscompleted86
2024-12-13P3Pfizer PFENCT03587116 A Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIHemophilia B; Hemophilia Acompleted212
2024-12-13P3Agios Pharmaceuticals, Inc. AGIONCT05175105 A Study to Evaluate the Efficacy and Safety of Mitapivat in Pediatric Participants With Pyruvate Kinase Deficiency (PKD) Who Are Not Regularly Transfused, FolloPediatric Pyruvate Kinase Deficiency; Pediatric Hemolytic Anemiaactive not recruiting30
2024-12-13P1/P2SOTIO Biotech a.s.NCT05525286 Clinical Trial of SOT102 Antibody Drug Conjugate in Patients With Advanced Gastric and Pancreatic AdenocarcinomaPancreatic Cancerterminated31
2024-12-13P2BeiGeneNCT05577702 Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable NoNon Small Cell Lung Cancercompleted121
2024-12-13P1/P2Marea TherapeuticsNCT05896254 Study of MAR001 in Adults With Metabolic DysfunctionHypertriglyceridemiacompleted55
2024-12-13P2Innovent Biologics (Suzhou) Co. Ltd.NCT06501534 A Dose Finding Study to Assess Efficacy and Safety of IBI128 in Chinese Gout SubjectsGout; Hyperuricemiacompleted84
2024-12-13P3Colgate Palmolive CLNCT06937697 Clinical of Hypersensitivity Reduction Efficacy on Two ToothpastesHypersensitivitycompleted87
2024-12-13P3Minghui Pharmaceutical (Hangzhou) LtdNCT07185282 A Phase 3 Study of MH004 Ointment in Patients With Mild to Moderate Atopic DermatitisAtopic Dermatitis (AD)completed375
2024-12-14 est.P2WntResearch ABNCT03883802 Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon CancerColon Cancerunknown100
2024-12-14P3Sanofi SNYNCT04684524 Dupilumab in Allergic Fungal Rhinosinusitis (AFRS)Allergic Fungal Rhinosinusitiscompleted62
2024-12-14P2Novartis Pharmaceuticals NVSNCT04886258 Study of Efficacy, Safety and Tolerability of DFV890 in Patients With Knee OsteoarthritisSymptomatic Knee Osteoarthritiscompleted115
2024-12-15 est.P2Catalysis SLNCT03549273 Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial LesionsCarcinoma; Neoplasia; Intraepithelial, Cervix; Glandular Neoplasms; Epithelial Neoplasm; Neoplasmsunknown62
2024-12-15P3Hoffmann-La RocheNCT04148911 A Study of Atezolizumab Plus Nab-Paclitaxel in the Treatment of Unresectable Locally Advanced or Metastatic PD-L1-Positive Triple-Negative Breast CancerTriple-Negative Breast Cancercompleted184
2024-12-16P3OctapharmaNCT04953884 Efficacy, PK, Immunogenicity and Safety of Wilate in Severe Von Willebrand Disease (VWD) Patients <6 Years of AgeVon Willebrand Diseasecompleted12
2024-12-16P3Bristol-Myers Squibb BMYNCT05002569 A Study to Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Resection of Stage III-IV MelanomaMelanomaterminated1093
2024-12-16P2Ilya PharmaNCT05608187 Evaluating Safety and Biological Effect on Wound Healing of ILP100-Topical in Subjects With Diabetic Foot UlcersWound Heal; Wound Healing Disturbance of; Wound Healing Disorder; Wound Healing Delayed; Diabetic Foterminated1
2024-12-16P3Ningbo Rongan Biological Pharmaceutical Co., Ltd.NCT05969626 Clinical Trial of Freeze-dried Human Rabies Vaccine (Without Serum Vero Cells)Rabiescompleted2460
2024-12-16P3LEO PharmaNCT06004050 A Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Delgocitinib Cream in Chinese Adults and Adolescents With Moderate to Severe Chronic Hand EczemaChronic Hand Eczemacompleted362
2024-12-16P3Colgate Palmolive CLNCT06598072 Comparative Study to Evaluate the Efficacy of an Alcohol-free Mouthwash Regimen With CPC+Zn, Flossing and Brushing, and an Alcohol-based Mouthwash Regimen With Gingival Bleeding; Plaque Induced Gingival Disease; Gingival Diseases; Gingivitis and Periodontal Dicompleted120
2024-12-17P2Biogen BIIBNCT02386553 A Study of Multiple Doses of Nusinersen (ISIS 396443) Delivered to Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular AtrophySpinal Muscular Atrophycompleted25
2024-12-17P1/P2Vivet Therapeutics SASNCT04537377 A Phase I/II Study of VTX-801 in Adult Patients With Wilson's DiseaseWilson's Diseaseactive not recruiting4
2024-12-17P2Mirum Pharmaceuticals, Inc. MIRMNCT04729751 A Study to Evaluate the Safety and Tolerability of Maralixibat in Infant Participants With Cholestatic Liver Diseases Including Progressive Familial IntrahepatiProgressive Familial Intrahepatic Cholestasis; Alagille Syndrome; Cholestatic Liver Diseasecompleted27
2024-12-17P2Novo Nordisk A/S NVONCT05016882 Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH)Non-alcoholic Steatohepatitiscompleted698
2024-12-17P2Incyte Corporation INCYNCT05267106 Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors HarGlioblastoma; Adult-type Diffuse Gliomasterminated83
2024-12-17P2VectivBio AGNCT05415410 Proof-of-concept Trial of Apraglutide in Acute Graft Versus Host Disease (aGVHD)GVHDterminated31
2024-12-17P3Ionis Pharmaceuticals, Inc. IONSNCT05552326 A Study of Olezarsen Administered Subcutaneously to Participants With Severe HypertriglyceridemiaSevere Hypertriglyceridemiacompleted446
2024-12-17P3Astellas Pharma Global Development, Inc.NCT05754333 A Study to Find Out if ASP5354 Can Clearly Help Show the Ureter During SurgeryIntraoperative Ureter Visualization; Abdominolpelvic Surgerycompleted107
2024-12-17P2Novartis Pharmaceuticals NVSNCT06031844 A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Coronary Heart Diseasecompleted24
2024-12-17P2Zhejiang Raygene Pharmaceuticals Co., LtdNCT06834399 TATE and KN046 in MCRCColorectal Cancer with Hepatic Metastasesterminated42
2024-12-18P2Blueprint Medicines CorporationNCT03580655 (PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With AdvanAdvanced Systemic Mastocytosis; Aggressive Systemic Mastocytosis; Systemic Mastocytosis With an Assocompleted107
2024-12-18P1/P2AO GENERIUMNCT04601584 GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALLB-precursor Acute Lymphoblastic Leukemia; ALL; GNR-084terminated14
2024-12-18P3Scholar Rock, Inc. SRRKNCT05156320 Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or RisdiplamSpinal Muscular Atrophy; Spinal Muscular Atrophy Type 3; Spinal Muscular Atrophy Type 2; SMA; Neuromcompleted188
2024-12-18P3Boehringer IngelheimNCT05321082 A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)Lung Diseases, Interstitialcompleted1178
2024-12-18P2/P3AN2 Therapeutics, Inc ANTXNCT05327803 Study of Epetraborole in Patients With Treatment-refractory MAC Lung DiseaseMAC Lung Disease; Treatment Refractory MAC Lung Diseaseterminated177
2024-12-18P3Novartis Pharmaceuticals NVSNCT05569174 Study of Efficacy and Safety of AIN457/Secukinumab in Patients With Rotator Cuff TendinopathyTendinopathycompleted62
2024-12-18P3Basilea PharmaceuticaNCT05856227 Late-onset Sepsis in Term and Pre-term Neonates and Infants up to 3 Months of AgeNeonatal Sepsiscompleted9
2024-12-18P2Escient Pharmaceuticals, IncNCT06077773 Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous UrticariaChronic Spontaneous Urticariaterminated113
2024-12-19P3CelgeneNCT02531126 An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative ColitisUlcerative Colitiscompleted877
2024-12-19P3Hoffmann-La RocheNCT04544436 A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)Multiple Sclerosisactive not recruiting864
2024-12-19P2Sylentis, S.A.NCT05637255 A Randomized, Double Masked, Parallel Group, Dose-finding Study to Evaluate SYL1801 in Patients With Neovascular Age-related Macular Degeneration (AMD)Wet Macular Degeneration; Neovascular Age-related Macular Degeneration; Macular Degenerationcompleted99
2024-12-19P3Hanmi Pharmaceutical Company Limited HAFCNCT05656092 A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric UlcerGastric Ulcercompleted199
2024-12-19P1/P2Novadip BiosciencesNCT05987033 Proof-of-concept Study With NVDX3 for Treatment of Distal Radius Fractures.Distal Radius Fracturescompleted11
2024-12-19P3Levomecor Inc.NCT06011577 Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDDMajor Depressive Disorder; Depressionterminated27
2024-12-20P2Kite, A Gilead CompanyNCT03105336 A Study of Axicabtagene Ciloleucel in Participants With Relapsed/Refractory Indolent Non-Hodgkin LymphomaFollicular Lymphoma; Marginal Zone Lymphoma; Indolent Non-Hodgkin Lymphomacompleted159
2024-12-20P3AstraZeneca AZNNCT04592913 Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction CancerGastrointestinal Neoplasms; Esophagogastric Junctionactive not recruiting957
2024-12-20 est.P2Code PharmaNCT05218356 Phase IIa Randomized Placebo Controlled Clinical Study of Codivir in Hospitalized Patients with Moderate COVID-19COVID-19unknown130
2024-12-20P3Exerkine CorporationNCT05384431 Can We Achieve 'high-quality' Weight Loss Through Supplementation and Exercise? the TRIM MUSCLE StudyOverweight; Obesitycompleted51
2024-12-20P2Longboard PharmaceuticalsNCT05626634 Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic EncephalopathyDevelopmental and Epileptic Encephalopathy; Dravet Syndrome; Lennox-Gastaut Syndromecompleted41
2024-12-20P2Qlaris Bio, Inc.NCT06249152 Qlaris Study of QLS-111 in Combination With a PGA for OAG and/or OHT PatientsOpen-angle Glaucoma (OAG); Ocular Hypertension (OHT); Glaucomacompleted36
2024-12-21P3Colgate Palmolive CLNCT06240481 Clinical Research Study to Assess the Efficacy of Two Brushing RegimensDental Plaque; Gingivitiscompleted90
2024-12-23P2Aadi Bioscience, Inc.NCT05103358 Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)Tumor; Tumor, Solid; Metastasis; Metastatic Cancer; Cancer; Cancer Metastatic; Tumors; Neoplasms; Necompleted128
2024-12-23P3Ascendis Pharma Endocrinology Division A/S ASNDNCT05171855 A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone DeficiencyAdult Growth Hormone Deficiency; Endocrine System Diseases; Hormone Deficiencycompleted220
2024-12-23P2AbbVie ABBVNCT05570006 Study of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative ColitisUlcerative Colitiscompleted30
2024-12-23P2Jeil Pharmaceutical Co., Ltd.NCT06144788 Evaluation of Efficacy and Safety When Administered JP-2266 in Type 2 Diabetes PatientsType 2 Diabetes Mellituscompleted161
2024-12-23P3AJU Pharm Co., Ltd.NCT06416865 Efficacy and Safety of AJU-C52 in Essential Hypertension PatientsEssential Hypertensioncompleted193
2024-12-23P3Beijing Minhai Biotechnology Co., LtdNCT07740733 Phase I/III Clinical Trial of Adsorbed Tetanus VaccineTetanus; Tetanus Vaccinecompleted1240
2024-12-24P3ViiV HealthcareNCT03016533 Dolutegravir Study in HIV-1 Participants Completing IMPAACT Studies P1093 and P2019HIV Infectionscompleted100
2024-12-24P3UCB Biopharma SRLNCT03250377 A Study to Test the Safety/ Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects >=16 Years of Age With Partial Seizures With or Without SecoPartial Seizures With or Without Secondary Generalization; Epilepsycompleted207
2024-12-24P2Tanabe Pharma America, Inc.NCT04683848 Study to Assess the Efficacy and Safety of MT-3921 in Subjects With Acute Traumatic Cervical Spinal Cord InjurySpinal Cord Injurycompleted72
2024-12-24P2Cardiff Oncology CRDFNCT04752696 Onvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic DuctPancreatic Ductal Adenocarcinomaterminated41
2024-12-26P3Genzyme, a Sanofi CompanyNCT04221451 A Multinational, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Pharmacodynamics, Pharmacokinetics, and Safety of Venglustat in LateTay-Sachs Disease; Sandhoff Diseaseterminated75
2024-12-26P2Viracta Therapeutics, Inc.NCT05011058 An Open-Label Phase 2 Trial of Nanatinostat Plus Valganciclovir in Patients With EBV+ Relapsed/Refractory LymphomasEpstein-Barr Virus Associated Lymphoma; EBV-Positive DLBCL, NOS; EBV-Related Non-Hodgkin Lymphoma; Eterminated102
2024-12-26P3Sanofi SNYNCT05468320 Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic PurpuraThrombotic Thrombocytopenic Purpuracompleted51
2024-12-26P2Apnimed APMDNCT06400615 Study That Tests AD109 in Patients Taking GLP-1 DrugsOSAcompleted40
2024-12-27P2Apeptico Forschung und Entwicklung GmbHNCT03567577 Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeability Oedema in Patients With Moderate-to-severe AARDScompleted92
2024-12-27P3GlaxoSmithKlineNCT03621670 Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to HeaInfections, Meningococcalcompleted1196
2024-12-27P3Hill Dermaceuticals, Inc.NCT05660382 Phase III Efficacy and Safety Study of Miconazole Oil for OtomycosisOtomycosiscompleted112
2024-12-27P1/P2Sanofi Pasteur, a Sanofi Company SNYNCT05687279 Study on a Live-attenuated Respiratory Syncytial Virus Vaccine for Assessment of Safety, Transmissibility, and Genetic Stability of the Vaccine Virus Among ClosRespiratory Syncytial Virus Infectioncompleted80
2024-12-27 est.P3Hyloris DevelopmentsNCT06143787 Effect of TXA Oral Sol 5% in Patients Treated With DOACs or VKA and Undergoing a Single or Multiple Tooth ExtractionBleeding From Teeth; Bleeding Prophylaxisunknown280
2024-12-27P3Novartis Pharmaceuticals NVSNCT06240741 A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in JapanNeuroendocrine Neoplasmscompleted71
2024-12-27P2GlaxoSmithKlineNCT06431607 A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older AdultsInfluenza, Humancompleted845
2024-12-27P2Zhejiang Yuejia Pharmaceuticals Co., Ltd.NCT07858344 Randomized, Double-blind, Placebo-controlled, Multicenter Phase IIb Clinical Trial of Spray YJ001 for the Treatment of Diabetic Peripheral Neuropathic PainDiabetic Peripheral Neuropathic Pain (DPNP)completed196
2024-12-29P2Shenzhen TargetRx Co., Ltd.NCT05955391 TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC)Non-small Cell Lung Canceractive not recruiting164
2024-12-29P2Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyNCT05974267 Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic Plasmodium Falciparum InfectioMalaria Infectioncompleted192
2024-12-29 est.P2HoHo BiotechNCT06401785 To Evaluate the Efficacy of Oral Molecular Hydrogen Supplement in Patients With Chronic DiseasesChronic Disease; Chronic Inflammationunknown60
2024-12-29P2VivaVision Biotech, IncNCT06679153 A Phase 2 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior UveitisAnterior Uveitiscompleted89
2024-12-30P2Kintara Therapeutics, Inc.NCT02717962 Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent SettingGlioma; Glioblastoma; Glioblastoma Multiforme; GBM; Brain Cancercompleted118
2024-12-30P1/P2BioAtla, Inc. BCABNCT03504488 CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2)Non Small Cell Lung Cancer; Triple Negative Breast Cancer; Melanoma; Head and Neck Cancercompleted132
2024-12-30P2StemCyte, Inc.NCT03979742 Umbilical Cord Blood Cell (MC001) Transplant Into Injured Spinal Cord Followed by the Locomotor TrainingSpinal Cord Injuriesterminated6
2024-12-30P1/P2Xynomic Pharmaceuticals, Inc.NCT04024696 A Clinical Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Abexinostat in Chinese PatientsNon Hodgkin Lymphomaactive not recruiting12
2024-12-30 est.P1/P2Ascentage Pharma Group Inc. AAPGNCT04358393 A Study of APG-115 Alone or Combined With Azacitidine in Patients With AML, CMML, or MDSAML; Acute Myeloid Leukemia; Chronic Myelomonocytic Leukemia; CMML; Myelodysplastic Syndromes; High-unknown69
2024-12-30P3GID BIO, Inc.NCT04440189 Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee OsteoarthritisOsteoarthritis, Kneeactive not recruiting114
2024-12-30 est.P3Beijing InnoCare Pharma Tech Co., Ltd.NCT04578613 ICP-022 Versus Chlorambucil Combined With Rituximab in the Treatment of Untreated CLL/SLLChronic Lymphocytic Leukemia; Small Lymphocytic Lymphomaunknown218
2024-12-30P3Organon and Co OGNNCT04626596 A Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060)Contraceptioncompleted498
2024-12-30 est.P2Conjupro Biotherapeutics, Inc.NCT04675450 NBP in Women With Metastatic Breast Cancer to Prevent Nab-paclitaxel Induced Toxic NeuropathyBreast Cancer; Peripheral Neuropathywithdrawn
2024-12-30P3Janssen Research & Development, LLCNCT04882098 A Study of Guselkumab in Participants With Active Psoriatic ArthritisArthritis, Psoriaticactive not recruiting1054
2024-12-30P3Cassava Sciences, Inc.NCT05026177 Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's DiseaseAlzheimer Diseaseterminated1125
2024-12-30 est.P2Agenus Inc. AGENNCT05033132 A Phase II Study of Balstilimab Independently or in Combination With Zalifrelimab in Advanced Cervical CancerCervical Cancerwithdrawn
2024-12-30P2Lepu Biopharma Co., Ltd.NCT05126719 A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent Metastatic Nasopharyngeal CarcinomaRecurrent or Metastatic Nasopharyngeal Carcinomaactive not recruiting238
2024-12-30 est.P3Suzhou Suncadia Biopharmaceuticals Co., Ltd.NCT05132413 A Study of SHR-1701 Plus Bevacizumab and Chemotherapy in Non-Small-Cell-Lung-CancerAdvanced or Metastatic Non-squamous Non-small-cell Lung Cancerunknown561
2024-12-30 est.P2RemeGen Co., Ltd.NCT05135715 A Study of RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression)Melanoma, Stage II; HER2-positive; Advanced Melanomaunknown50
2024-12-30 est.P3Paracrine, INC.NCT05148598 ADRCs in The Treatment of Hand Dysfunction Due to SclerodermaScleroderma, Diffuseunknown174
2024-12-30P2Treeway B.V.NCT05323812 ASURE: Alzheimer Study Using oRal EdaravoneAlzheimer Diseasecompleted61
2024-12-30 est.P2/P3Qilu Pharmaceutical Co., Ltd.NCT05576272 A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal CarcinomaNasopharyngeal Carcinomaunknown460
2024-12-30 est.P3Taizhou Hanzhong biomedical co. LTDNCT05647954 A Study of HX008 Plus Transcatheter Arterial Chemoembolization (TACE) in the First-Line Treatment of Subjects With Stage IV (M1c) Melanoma That is Metastatic toMelanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms byunknown350
2024-12-30 est.P3Jiangsu HengRui Medicine Co., Ltd.NCT05751850 HR070803 in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Advanced Pancreatic CancerFirst-line Treatment of Advanced Pancreatic Cancerunknown778
2024-12-30P3Incyte Corporation INCYNCT05764161 A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)Prurigo Nodulariscompleted190
2024-12-30 est.P1/P2Zhejiang Yangli Pharmaceutical Technology Co., Ltd.NCT05927779 Study of TFX06 in Women With Advanced Breast Cancer.ER+, HER2- Advanced Breast Cancer; Metastatic Breast Cancerunknown74
2024-12-30 est.P2Genrix (Shanghai) Biopharmaceutical Co., Ltd.NCT06015243 The Study of Long-term Outcomes of GR1802 in Patients With Chronic Rhinosinusitis With Nasal PolypsChronic Rhinosinusitis With Nasal Polypsunknown70
2024-12-30 est.P2Convalife (Shanghai) Co., Ltd.NCT06029816 Neratinib Tablets in the Treatment of Advanced NSCLC With Rare EGFR MutationsNSCLCunknown42
2024-12-30 est.P3Jiangsu Hansoh Pharmaceutical Co., Ltd.NCT06110663 A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKNon-Small Cell Lung Cancerunknown314
2024-12-30 est.P2PharmaJet, Inc.NCT06142461 Safety and Immunogenicity of HPV Vaccine Administered Intradermally and Intramuscularly Via Needle-Free Injection SystemVaccine Reactionwithdrawn
2024-12-30 est.P3Beijing Zhifei Lvzhu Biopharmaceutical Co., LtdNCT06314659 Immunogenicity and Safety of Group A and C Meningococcal Polysaccharide Conjugate Vaccine in Volunteers Aged 3-5 MonthsHealthy Populationunknown630
2024-12-30 est.P3Beijing Zhifei Lvzhu Biopharmaceutical Co., LtdNCT06314867 Clinical Study on Lot-to-lot Consistency and Immune Persistence of Three Commercial Batches of PPSV23Healthy Volunteersactive not recruiting990
2024-12-30P3Tris Pharma, Inc.NCT06545097 A Study of Cebranopadol for the Treatment of Acute Pain After AbdominoplastyAcute Paincompleted279
2024-12-31 est.P1/P2Ascend Biopharmaceuticals Ltd AAWHNCT03208296 Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS)Basal Cell Carcinoma in Basal Cell Nevus Syndromesuspended24
2024-12-31 est.P3Eusol Biotech Co., Ltd.NCT03229031 A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Safety and Efficacy of ES135 in Subjects With Spinal Cord InjurySpinal Cord Injuriessuspended160
2024-12-31 est.P1/P2Shanghai Unicar-Therapy Bio-medicine Technology Co.,LtdNCT03275493 CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia; CD19 Positive; Relapse; Refractoryunknown40
2024-12-31 est.P3NeuroRx, Inc.NCT03396068 NRX-101 for Maintenance of Remission From Severe Bipolar Depression in Patients With Suicidal IdeationBipolar Depression; Suicidal Ideationunknown72
2024-12-31 est.P3NeuroRx, Inc.NCT03396601 NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar DepressionBipolar Depression; Suicidal Ideationunknown150
2024-12-31 est.P1/P2Shanghai Unicar-Therapy Bio-medicine Technology Co.,LtdNCT03614858 CD19/CD22-targeted Chimeric Antigen Receptor Engineered T Cell (CART) in B-Cell Acute Lymphoblastic Leukemia.Leukemia, B-cellunknown20
2024-12-31P1/P2RAPT Therapeutics, Inc., a member of the GSK plc group of companiesNCT03674567 Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With PembrolizumabAdvanced Cancercompleted323
2024-12-31 est.P2Aadi Bioscience, Inc.NCT03747328 ABI-009 (Nab-sirolimus) in Patients With Genetically-confirmed Leigh or Leigh-like SyndromeLeigh Syndromewithdrawn
2024-12-31 est.P1/P2Beijing InnoCare Pharma Tech Co., Ltd.NCT03758664 Clinical Study of ICP-192 in Solid Tumors PatientsSolid Tumorunknown56
2024-12-31 est.P1/P2Shanghai Unicar-Therapy Bio-medicine Technology Co.,LtdNCT03896854 CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)Acute Myeloid Leukemiaunknown15
2024-12-31 est.P1/P2CARsgen Therapeutics Co., Ltd.NCT03915184 Clinical Trial to Evaluate Zevor-cel (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 2)Multiple Myelomaactive not recruiting105
2024-12-31 est.P1/P2CARsgen Therapeutics Co., Ltd.NCT03975907 Clinical Trial to Evaluate CT053 in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 1)Multiple Myelomaunknown121
2024-12-31 est.P1/P2Effector TherapeuticsNCT04092673 Study of eFT226 in Subjects With Selected Advanced Solid Tumor MalignanciesSolid Tumor, Adultunknown30
2024-12-31P3Amicus TherapeuticsNCT04138277 A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With Late-Onset Pompe Disease (LOPD)Pompe Disease (Late-onset)completed119
2024-12-31 est.P3Qilu Pharmaceutical Co., Ltd.NCT04233151 QL1203 In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy and SafetyMetastatic Colorectal Cancerunknown590
2024-12-31 est.P1/P2Beta Pharma (Suzhou) Co., Ltd.NCT04282031 A Study of BPI-1178 in Patients With Advanced Solid Tumor and HR+/HER2- Breast CancerAdvanced Solid Tumor; HR+/HER2- Breast Cancerunknown224
2024-12-31P2Zhejiang DTRM BiopharmaNCT04305444 Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's LymphomasRelapsed Chronic Lymphocytic Leukemia; Refractory Chronic Lymphocytic Leukemia; Diffuse Large B Cellterminated55
2024-12-31 est.P1/P2Y-mAbs TherapeuticsNCT04315246 177Lu-DTPA-Omburtamab Radioimmunotherapy for Leptomeningeal Metastasis From Solid Tumors (Breast, NSCLC, Malignant Melanoma)Leptomeningeal Metastasis; Solid Tumor, Adultwithdrawn
2024-12-31 est.P1/P2BioIntegrateNCT04424394 DualStim Therapy With or Without Umbilical Cord Derived Wharton's Jelly for Erectile DysfunctionErectile Dysfunctionunknown60
2024-12-31 est.P2Beijing InnoCare Pharma Tech Co., Ltd.NCT04492293 An Efficacy and Safety Study of ICP-192 in Subjects With Bladder Urothelial CancerBladder Urothelial Cancerunknown115
2024-12-31P2Candel Therapeutics, Inc. CADLNCT04495153 CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLCNon Small Cell Lung Canceractive not recruiting90
2024-12-31 est.P2TJ Biopharma Co., Ltd.NCT04600817 A Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent ChemoradiotherapNewly Diagnosed Glioblastomaunknown160
2024-12-31P3Jiangsu HengRui Medicine Co., Ltd.NCT04737850 Hetrombopag for Pediatric Patients With Chronic Immune ThrombocytopeniaImmune Thrombocytopeniacompleted100
2024-12-31P3Shanghai Henlius BiotechNCT04740671 A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMDAge Related Macular Degenerationcompleted410
2024-12-31P3argenx ARGXNCT04818671 Evaluating the Long-Term Safety and Tolerability of Efgartigimod PH20 SC Administered Subcutaneously in Patients With Generalized Myasthenia GravisGeneralized Myasthenia Graviscompleted184
2024-12-31 est.P1/P2Kartos Therapeutics, Inc.NCT04835584 KRT-232 and TKI Study in Chronic Myeloid LeukemiaChronic Myeloid Leukemiaunknown109
2024-12-31P3Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT04854668 A Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal CancerMetastatic Colorectal Canceractive not recruiting748
2024-12-31P3Levomecor Inc.NCT04855747 A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD)Major Depressive Disorder; Depressionterminated236
2024-12-31 est.P3Chipscreen Biosciences, Ltd.NCT04921527 Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian CancerOvarian Cancer; Relapsed or Refractory; Chiauranib; Paclitaxelunknown454
2024-12-31 est.P1/P2SUNHO(China)BioPharmaceutical CO., Ltd.NCT04934514 Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid TumorsAdvanced Solid Tumorunknown97
2024-12-31 est.P1/P2Betta Pharmaceuticals Co., Ltd.NCT04946890 A Study of MRX2843 in Subjects With Relapsed/Refractory Acute Myeloid LeukemiaAcute Myeloid Leukemia Leukemiaunknown104
2024-12-31 est.P2Betta Pharmaceuticals Co., Ltd.NCT05007938 Befotertinib and Icotinib in Treatment-naive Patients With Advanced EGFR-Mutant Lung CancerNon-Small Cell Lung Cancerunknown30
2024-12-31P1/P2BioGaia Pharma ABNCT05118919 A Safety Study of Lactobacillus Reuteri BGP-014 in Patients With Ulcerative ColitisUlcerative Colitiscompleted35
2024-12-31 est.P2Genexine, Inc.NCT05191784 GX-I7 in Combination With Bevacizumab in Recurrent Glioblastoma (GBM) PatientsRecurrent Glioblastomaunknown20
2024-12-31P1/P2LaNova Australia Pty LimitedNCT05199753 Study of LM-108 as a Single Agent or in Combination With Anti-PD-1 Antibody in Subjects With Advanced Solid TumoursAdvanced Solid Tumorcompleted78
2024-12-31P1/P2Antengene CorporationNCT05265975 A Study of ATG-010 in Combination With Lenalidomide and Rituximab (R2) in Adults With DLBCL and iNHLDiffuse Large B-cell Lymphoma; Indolent Non-Hodgkin Lymphomaterminated54
2024-12-31 est.P3Chengdu Easton Biopharmaceuticals Co,LtdNCT05318326 A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial to Evaluate the Clinical Efficacy and Safety of Yogliptin TabletsType 2 Diabetesunknown450
2024-12-31P2Cassava Sciences, Inc.NCT05352763 Open-Label Extension of the PTI-125-04 Study in Mild-to-Moderate Alzheimer's DiseaseAlzheimer's Diseaseterminated90
2024-12-31 est.P1/P2Laboratoires TheaNCT05389267 Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients.Glaucoma; Ocular Hypertensionactive not recruiting120
2024-12-31P2Jiangsu Alphamab Biopharmaceuticals Co., LtdNCT05420220 Study of KN046 in Subjects With Advanced Non-Small Cell Lung CancerAdvanced Non-small Cell Lung Cancercompleted95
2024-12-31 est.P2Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.NCT05420779 A Study to Evaluate the Efficacy and Safety of TSL-1502 Capsules in Breast Cancer Patients With Germline BRCA MutationsBreast Cancer Metastaticunknown125
2024-12-31 est.P2AB ScienceNCT05449444 Masitinib for the Treatment of Severe Mast Cell Activation SyndromeMast Cell Activation Syndromeunknown72
2024-12-31 est.P2Biozeus Biopharmaceutical S.A.NCT05558007 Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized PatientsErectile Dysfunction Following Radical Prostatectomy; Erectile Dysfunction; Prostate Cancer; Radicalunknown72
2024-12-31 est.P2FutureChemNCT05579184 [Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application_2Metastatic Castration-resistant Prostate Cancer, mCRPCunknown20
2024-12-31P2Shanghai Pharmaceuticals Holding Co., LtdNCT05593575 Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney DiseaseDiabetic Kidney Diseasecompleted305
2024-12-31P3Sumitomo Pharma America, Inc.NCT05605964 Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide AcetateProstate Cancercompleted387
2024-12-31 est.P2CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT05616494 A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic CancerPancreatic Cancerunknown53
2024-12-31 est.P2Tasly Pharmaceutical Group Co., LtdNCT05632861 HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR)NASHunknown76
2024-12-31P2Hutchmed HCMNCT05713110 A Study of Tazemetostat in Combination With HMPL-689 in Patients With Relapsed/Refractory LymphomaRelapsed/Refractory Lymphomacompleted61
2024-12-31 est.P1/P2Shanghai Kanda Biotechnology Co., Ltd.NCT05723432 KD6001 in Combination With Anti-PD-1 Antibody in Patients With Advanced MelanomaMelanomaunknown84
2024-12-31 est.P2/P3Qilu Pharmaceutical Co., Ltd.NCT05802342 A Multicenter, Randomized, Double-blind Phase II Trial to Evaluate GM1 Prevention of Peripheral Neuropathy in Patients With Breast CancerTo Evaluate the Effectiveness of GM1 in the Prevention of Albumin-paclitaxel Therapy Induced Peripheunknown150
2024-12-31 est.P2Sinew Pharma Inc.NCT05842733 A Novel, Potent and Non-addictive Analgesic of Combinations for Knee Replacement Moderate to Severe Pain ManagementPain, Postoperativeunknown36
2024-12-31 est.P1/P2Suzhou Suncadia Biopharmaceuticals Co., Ltd.NCT05845138 A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression.Breast Cancerunknown116
2024-12-31 est.P2CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT05875428 Mitoxantrone Hydrochloride Liposome Injection in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)Diffuse Large B-Cell Lymphomaunknown104
2024-12-31 est.P2HK inno.N CorporationNCT05933031 Exploratory Study to Standard Triple Therapy With Tegoprazan(by Dose) in H. Pylori Positive PatientsHelicobacter Pylori Infectionunknown381
2024-12-31 est.P1/P2Sequana Medical N.V.NCT05965934 Management of Volume Overload HF Patients by Individual DSR Treatment adJustment-a clinicAl inVestigation of InfusatE2.0Heart Failure; Volume Overloadunknown33
2024-12-31 est.P2Hansoh BioMedical R&D CompanyNCT06001255 ARTEMIS-003: HS-20093 in Patients With Metastatic Castrate-resistant Prostate Cancer (mCRPC) and Advanced Solid TumorsMetastasis Castration Resistant Prostate Cancer(mCRPC)unknown120
2024-12-31P2BeiGeneNCT06029127 A Study of Gimistotug (BGB-A445) in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung CancerNon-Small Cell Lung Cancercompleted35
2024-12-31P2Beijing Suncadia Pharmaceuticals Co., LtdNCT06220123 A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer SurgePreventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgerycompleted225
2024-12-31P3Axsome Therapeutics, Inc. AXSMNCT06360419 Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using SolriamfetolMajor Depressive Disordercompleted346
2024-12-31P2SpinogenixNCT06413537 Study of SPG601 in Adult Men With Fragile X SyndromeFragile X Syndromecompleted10
2024-12-31 est.P2/P3Shanghai YingLi Pharmaceutical Co. Ltd.NCT06548347 A Phase II/III Study of Linperlisib Plus CHOP Versus CHOP in Patients With Newly Diagnosed Peripheral T Cell LymphomaPeripheral T Cell Lymphomanot yet recruiting606
2024-12-31 est.P2/P3Taejoon Pharmaceutical Co., Ltd.NCT06609525 Comparing Efficacy and Safety of CTO0303 in Pediatric SubjectsPupillary Dilation Effect During Cycloplegic Refractionunknown156
2024-12-31 est.P2NGM Biopharmaceuticals, IncNCT07511972 Study of NGM707 in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor MalignanciesCRCwithdrawn
2024-12-31P1/P2Gritgen Therapeutics Co., Ltd.NCT07548411 To Evaluate the Safety and Efficacy of GS1191-0445 Injection in the Treatment of Severe Hemophilia ASevere Hemophilia Aactive not recruiting7

← 2024-11 | 2025-01 →

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.